Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs Matinas Biopharma Holdings, Inc. (MTNB)

Avenue Therapeutics, Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. Matinas Biopharma Holdings, Inc. is the larger, with a market value of $1.1M against $680.0K — 1.7× the size. Across the 11 metrics below, Avenue Therapeutics, Inc. leads on 7 and Matinas Biopharma Holdings, Inc. on 4.

Valuation

Metric ATXI MTNB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.12 9.40
P/B 2.49 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.05 0.04 0.66
EV/Sales n/m (0.06) 9.02
Earnings yield (197.67%) (1,403.30%) (32.88%)
Free cash flow yield (97.68%) (1,142.24%) (23.13%)

Profitability

Metric ATXI MTNB Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) (154.28%) (51.96%)
Return on assets (90.50%) (98.53%) (46.06%)
Return on invested capital 0.00% (419.27%) 0.00%

Growth

Metric ATXI MTNB Biotechnology median
Revenue growth (TTM) — 2,135.91% 6.76%
EPS growth (last fiscal year) 94.11% 59.84% 29.88%
Revenue growth, 5-year CAGR — 55.69% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI MTNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.40 0.85 4.97
Net debt to EBITDA 0.93 0.62 1.01

Dividend

Metric ATXI MTNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATXI MTNB Biotechnology median
Market cap 680.00k 1.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack